Protection and waning of Natural and Hybrid Immunity to SARS CoV 2 Isra Zaman17 Jun 2022 12:31 PM ISTAmong persons who had been previously infected with SARS-CoV-2, protection against reinfection decreased as the time increased since the last...
Researchers identify new tool that eliminates race as determining factor for diagnosing Kidney failure Dr. Kamal Kant Kohli16 Jun 2022 9:00 AM ISTSince 2009, the most commonly used blood test to evaluate kidney function has used equations that include race as a determining factor. The equations...
Three-drug therapy with autologous stem cell transplant improves survival in multiple myeloma: NEJM Dr. Kamal Kant Kohli15 Jun 2022 8:00 PM ISTResearchers have found in a new study appearing in New England journal of Medicine that among adults with multiple myeloma, RVD plus ASCT was...
Tirzepatide new treatment option for people who are overweight or have obesity: SURMOUNT-1 clinical trial Dr. Kamal Kant Kohli6 Jun 2022 9:45 AM ISTIn the 72-week, phase III SURMOUNT-1 clinical trial the researchers have reported that combination GIP and GLP-1 receptor agonist tirzepatide...
Tranexamic acid significantly lowers composite bleeding in patients undergoing noncardiac surgery: POISE trial Isra Zaman31 May 2022 7:02 PM ISTAmong patients undergoing noncardiac surgery, the incidence of the composite bleeding outcome was significantly lower with tranexamic acid than with...
Reloxaliase reduces urinary oxalate excretion in patients with enteric hyperoxaluria: URIROX-1 trial Medha Baranwal16 May 2022 10:45 AM ISTUSA: A recent study in NEJM Evidence showed that in patients with enteric hyperoxaluria, treatment with reloxaliase for 4 weeks reduced the excretion...
Antibody combo of Tixagevimab and Cilgavimab effectively prevents COVID-19: NEJM Medha Baranwal23 April 2022 10:15 AM ISTUK: Single dose of AZD7442 (Tixagevimab-Cilgavimab) is effective for COVID-19 prevention sans any evident safety concerns. Further administration of...
Calorie restricted diet added to time-restriction fails to boost weight loss: NEJM Medha Baranwal22 April 2022 11:00 AM ISTChina: Time-restricted eating is an intermittent-fasting regimen that involves a shortened period of time for eating within each 24-hour period. It is...
Oral tebipenem pivoxil hydrobromide noninferior to IV ertapenem for complicated UTI: NEJM Medha Baranwal7 April 2022 10:30 AM ISTUSA: Oral tebipenem pivoxil hydrobromide is noninferior and has a similar safety profile to intravenous ertapenem in the treatment of complicated...
Higher dose of Primaquine effective for malaria relapse prevention: NEJM Medha Baranwal1 April 2022 8:30 PM ISTBrazil: A higher dose of (7.0 mg per kilogram) of a primaquine-based regimen is more effective for preventing relapses of Plasmodium vivax malaria...
Mini-slings non-inferior to mid-urethral slings for female stress urinary incontinence: NEJM Medha Baranwal31 March 2022 9:00 AM ISTUSA: A recent study in the New England Journal of Medicine showed single-incision mini-slings to be noninferior to standard mid-urethral slings in...
Breaking News: NEJM study prompts WHO for shorter treatment regime for treating TB in children Hina Zahid11 March 2022 4:03 PM IST4 months Anti TB treatment as good as 6 months regimen in kids with non severe disease, said NEJM report
